Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.

Tu CY, Chen HL, Wu YH, Wu MJ

Open source

DOI
10.1016/j.diabres.2026.113573
Published
2026 Sep 20
Container
Diabetes research and clinical practice
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.diabres.2026.113573,
  title = {Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.},
  author = {Tu CY and Chen HL and Wu YH and Wu MJ},
  year = {2026},
  journal = {Diabetes research and clinical practice},
  doi = {10.1016/j.diabres.2026.113573},
  url = {https://doi.org/10.1016/j.diabres.2026.113573}
}

RIS

TY  - JOUR
TI  - Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.
AU  - Tu CY
AU  - Chen HL
AU  - Wu YH
AU  - Wu MJ
PY  - 2026
JO  - Diabetes research and clinical practice
DO  - 10.1016/j.diabres.2026.113573
UR  - https://doi.org/10.1016/j.diabres.2026.113573
ER  - 

APA

CY, T., HL, C., YH, W., & MJ, W. (2026). Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.. Diabetes research and clinical practice. https://doi.org/10.1016/j.diabres.2026.113573

Source records